Bengaluru-based specialty chemicals startup Scimplify has raised $25 million in an all-equity strategic funding round led by Hitachi Ventures, the company confirmed this week, in a deal that pushes its total equity funding to $80 million and sets up a push into US manufacturing. The round, reported by TechCrunch, brings two new strategic backers onto Scimplify’s cap table: German chemicals and adhesives giant Henkel, and US-based plastics and chemicals manufacturer Teknor Apex.
For a tech audience that spends more time reading about large language models than about chemical synthesis, the Scimplify raise lands at an odd intersection: it is a materials-science story that is really a software story. The company builds and sells specialty chemicals, but it does so through an AI platform called Scinode that predicts synthesis routes, simulates factory production, and coordinates R&D, quality, sourcing, and regulatory workflows. That software layer, not the chemistry alone, is why Hitachi’s venture arm and two industrial manufacturers just wrote checks, and why the deal is being watched well outside India’s startup scene.
Don't miss new tech stories on Google
Add Tech Insider once in the Google app and our stories appear in your news suggestions.
The $25 Million Round: Who’s Backing Scimplify Now
Scimplify’s new round is structured as an all-equity strategic investment rather than a traditional venture round, a distinction that matters because every new investor named in the deal is also described as a customer or manufacturing partner. Hitachi Ventures led the round, with Henkel and Teknor Apex joining as new investors. Existing backers Accel India, Bertelsmann India Investments, Omnivore, and 3one4 Capital also participated, according to a report from The Economic Times.
The structure signals something specific about where Scimplify sits in the specialty chemicals supply chain: it is not raising purely financial capital, it is raising capital from the companies that will eventually buy its output or help it make more of it. Teknor Apex, a US-based compounder of plastics and elastomers, is expected to become a manufacturing partner as Scimplify builds out its American footprint. That dual role, investor and future supplier or customer, is becoming a recognizable pattern in deep-tech and materials funding, where strategic capital often moves faster than pure financial capital because the backer already understands the technical risk.
Scimplify has declined to disclose its valuation following the round, a common move for strategically-backed private companies that want to avoid setting a public benchmark ahead of future fundraising. The $25 million figure brings total equity funding raised by the company to $80 million since its founding, according to multiple reports tracking the deal.
Inside Scimplify’s Specialty Chemicals Platform
Scimplify describes itself as a maker of specialty chemicals and critical materials, a category that spans the inputs used in semiconductors, defense systems, energy storage, batteries, and AI infrastructure. Those four end markets are not a random list. Each one depends on a narrow set of high-purity chemical inputs that are currently produced by a small number of global suppliers, many of them concentrated in China. Scimplify’s pitch is that it can serve as an alternative source by combining Indian manufacturing capacity, much of which sits underused today, with AI-driven process engineering.
What Scimplify Actually Makes
The company’s output falls into the category of specialty and fine chemicals rather than bulk commodity chemicals. These are lower-volume, higher-complexity materials where the value lies in purity, consistency, and speed of qualification rather than in scale alone. That is precisely the segment where semiconductor fabs, battery makers, and defense contractors are most exposed to supply concentration risk, because switching suppliers for a high-purity input typically requires lengthy requalification.
Where It Operates Today
Scimplify is headquartered in Bengaluru, India, and has built its production network around Indian manufacturing partners. The new funding is earmarked to extend that network into the United States and Japan over the coming year, according to the company’s own statements reported by TechCrunch and corroborated by other outlets covering the round.
Henkel and Teknor Apex Step In as Strategic Investors
The arrival of Henkel and Teknor Apex as named investors is arguably the most concrete signal in this round. Henkel, the German consumer and industrial chemicals group best known for adhesives brands, and Teknor Apex, a US compounder of plastics and elastomers, are both existing buyers of specialty chemical inputs at industrial scale. Their decision to invest directly in a supplier, rather than simply signing a procurement contract, suggests both companies see Scimplify’s AI-assisted production model as durable enough to justify equity exposure, not just a one-off sourcing relationship.
Teknor Apex’s role goes further than a passive investment. Reports indicate the company is expected to become a manufacturing partner for Scimplify’s planned US expansion, lending its existing American plant infrastructure to help qualify new production lines. That kind of partnership can cut years off the timeline a startup would otherwise need to stand up its own US manufacturing from scratch, because it borrows an established partner’s regulatory standing and operational know-how rather than building both from zero.
| Investor | Type | Role in Round |
|---|---|---|
| Hitachi Ventures | Corporate VC (new) | Lead investor |
| Henkel | Strategic/industrial (new) | New investor, customer |
| Teknor Apex | Strategic/industrial (new) | New investor, expected US manufacturing partner |
| Accel India | Venture capital (existing) | Participating investor |
| Bertelsmann India Investments | Corporate VC (existing) | Participating investor |
| Omnivore | Venture capital (existing) | Participating investor |
| 3one4 Capital | Venture capital (existing) | Participating investor |
From $80 Million Total: Scimplify’s Funding Journey
The $25 million strategic round pushes Scimplify’s cumulative equity funding to $80 million, a figure confirmed across multiple reports covering the deal, including coverage from Sacra, which tracks private company revenue and funding data. That total reflects a company that has steadily added capital from both pure financial investors, such as Accel India and 3one4 Capital, and increasingly from strategic industrial partners as it has matured.
The shift in investor composition, from mostly venture capital in earlier rounds to a strategic, customer-led round now, mirrors a broader pattern in specialty materials and deep-tech investing. As a startup’s technology moves from pilot to industrial scale, the investors who matter most change too: financial backers who valued growth metrics give way to industrial partners who need working supply chains and are willing to pay for priority access and oversight. That shift is itself a data point on how close Scimplify believes it is to commercial-scale production outside India.
The US Expansion Plan and Its Conflicting Numbers
Scimplify’s stated plan is to use the new capital to build out research, processing, and manufacturing capabilities in the United States. That includes physical processing capacity and the qualification of American manufacturing partners for technology transfer, pilot batches, and validation batches, according to a report from The AI Insider. Those three stages, technology transfer, pilot batches, and validation batches, are the standard checkpoints a specialty chemical producer has to clear before a customer will accept material at commercial volume, and each stage typically takes months rather than weeks.
Where reports diverge is on exactly how much of the new capital goes toward that US buildout. Scimplify cofounder Sachin Santhosh was quoted saying the company plans to spend approximately $7.5 million of the new funding on US expansion, while cautioning that the allocation could change as plans evolve. No other report cites a US-investment figure; the only reported allocation for US expansion is the ~$7.5 million figure from cofounder Sachin Santhosh. The $10 million figure circulating elsewhere refers to Scimplify’s past US annualized revenue run rate (which has since grown sixfold to about $60 million), not an investment amount. Tech Insider is flagging that discrepancy rather than picking a winner, since both figures trace back to the same funding announcement and neither outlet has issued a correction.
| Reported Use of Funds | Amount | Source of Figure |
|---|---|---|
| US expansion (per cofounder Sachin Santhosh) | ~$7.5 million | Reported by outlets citing Santhosh directly; allocation may change |
| US investment over two years (alternate report) | ~$10 million | Separate outlet report; conflicts with the $7.5M figure |
| Scinode AI platform development | $2 million | Company-stated allocation |
| Total new round | $25 million | Confirmed across all reports |
What is not in dispute is the $2 million the company says it will put into further development of Scinode, its AI platform, and the technical priorities for the US operation: rare-earth and critical-metals purification and processing, plus high-purity semiconductor and battery chemicals. Those priorities line up directly with the categories of materials the US and allied governments have flagged as supply-chain vulnerabilities over the past two years.
Scinode: The AI Software Platform Behind the Manufacturing Push
For readers who track developer and AI tooling rather than chemicals, Scinode is the part of this story that belongs in the same conversation as other AI-platform funding news. Scimplify describes Scinode as software that predicts synthesis routes, simulates factory production before a line is built, and coordinates the handoffs between R&D, quality control, sourcing, and regulatory teams, functions that at most chemical manufacturers still run on spreadsheets and email threads.
That framing, applying AI prediction and simulation to a physical-manufacturing workflow, puts Scinode in the same broad category as the AI data science agent platforms and coding agent tools that have drawn large rounds elsewhere in 2026. The difference is that Scinode’s outputs are chemical formulas and production schedules rather than application code, but the underlying bet, that software can compress a slow, expert-dependent process into something faster and more repeatable, is identical. Cofounder Sachin Santhosh has pointed to concrete evidence of that compression, saying the company has in some cases gone from receiving a customer’s requirements to delivering finished material in two months, compared with the 12 to 18 months such work would typically take, a claim reported directly by TechCrunch.
A $2 million earmark sounds modest next to the $25 million headline figure, but it is worth noting that Scinode is the layer every other part of the US expansion depends on. Without software that can predict which synthesis route will actually work on a new line before capital is committed to building it, the technology-transfer and pilot-batch process Scimplify describes would take considerably longer and cost considerably more.
Why Critical Materials, Semiconductors, and AI Infrastructure Matter Now
Scimplify’s product categories, materials for semiconductors, defense, energy, batteries, and AI infrastructure, read like a checklist of the sectors most exposed to supply-chain concentration risk in 2026. Semiconductor fabs need ultra-high-purity chemicals for etching and cleaning processes; battery makers need consistent, qualified chemical precursors at growing volume as EV and grid-storage demand rises; and the current AI infrastructure buildout, with hyperscalers and chipmakers racing to add data center capacity, depends on a steady upstream supply of specialty materials that rarely makes headlines until it runs short.
That is also the framing used in coverage of the round itself. TechCrunch’s reporting on the deal explicitly positions Scimplify as a company aiming to challenge concentrated international control over critical materials production, a framing Hitachi Ventures appears to share given its decision to lead the round. For a corporate venture arm owned by one of Japan’s largest industrial conglomerates, backing an Indian alternative-materials supplier is as much a supply-chain hedge as it is a financial bet.
Competitive Landscape: Where Scimplify Sits Among AI-Driven Materials Platforms
Scimplify is not alone in trying to apply AI and software to materials production, but its specific combination, Indian manufacturing capacity paired with an AI platform for synthesis prediction and factory simulation, plus strategic capital from the customers it serves, is a distinct model. Most competitors in the broader AI-for-materials space fall into two camps: pure-software companies that sell prediction tools to existing chemical manufacturers without owning production, and legacy specialty chemical producers that are bolting AI tools onto decades-old plants.
Scimplify’s strategic-round structure, with buyers like Henkel and Teknor Apex investing directly, is also a sharper version of a trend seen elsewhere in AI infrastructure funding this year, where large customers take equity stakes in suppliers to lock in capacity and influence product roadmaps rather than relying solely on long-term supply contracts. That approach reduces a startup’s exposure to pure financial-market swings but can also tie its growth more tightly to a small number of large customers’ own demand cycles, a trade-off Scimplify appears to have accepted in exchange for faster access to US manufacturing know-how through Teknor Apex.
Historical Context: India’s Specialty Chemicals Push
Scimplify’s raise arrives against the backdrop of a multi-year effort by Indian manufacturers and investors to position the country as an alternative base for specialty and fine chemical production, a shift accelerated by global buyers looking to diversify away from single-country sourcing. India’s existing chemical manufacturing base is large but has historically focused on bulk and commodity chemicals rather than the high-purity, low-volume specialty segment that commands better margins and tighter customer relationships.
Scimplify’s pitch, that AI-driven process design can unlock underused Indian manufacturing capacity for higher-value specialty output, fits a pattern seen across India’s broader tech and manufacturing sectors over the past two years, where software layers are increasingly used to make existing physical infrastructure more productive rather than building new infrastructure from scratch. The $80 million in cumulative funding the company has now raised, split across venture and strategic capital, suggests investors see that software-plus-manufacturing model as more durable than a pure-software or pure-manufacturing play alone.
Market Impact: What This Means for the AI Hardware Supply Chain
For an audience focused on AI and hardware, the practical takeaway from Scimplify’s round is upstream rather than immediate. The company is not building chips, servers, or data centers, but it is aiming to supply some of the specialty chemical inputs that semiconductor and battery manufacturers depend on, categories where a shortage or quality problem several steps up the supply chain can quietly stall production lower down it. If Scimplify’s US processing capacity comes online as planned over the next year, it would add a qualified alternative source for at least some of those inputs, reducing concentration risk for buyers who currently rely on a narrow set of established suppliers.
That kind of upstream diversification tends to matter most during periods of supply stress, when buyers discover how dependent they are on a handful of qualified vendors. Whether Scimplify’s US buildout happens fast enough to matter during the current AI infrastructure boom depends heavily on how quickly it can move through the technology-transfer, pilot-batch, and validation-batch stages it has outlined, each of which carries real technical and regulatory risk that funding alone cannot eliminate.
Expert Voices: What Backers and Founders Are Saying
Radhika Ananth, Managing Director of India at Hitachi Ventures, framed the investment as a bet on unlocking capacity that already exists rather than building something new from the ground up. “Specialty chemicals demand has outgrown the models built to serve it. India has the manufacturing capacity, but much of it sits underused, without the science and quality systems global customers require. We believe Scimplify is building the platform that closes this gap,” she said, according to Global Venturing.
Cofounder Sachin Santhosh, in comments reported by VCCircle, was direct about why the round’s investors look more like customers than typical venture backers. “The investors are strategic investors who are also our customers. These include Hitachi, Teknor Apex, and Henkel. We will also announce a Japanese company as an investor soon,” Santhosh said. That last detail, an as-yet-unnamed Japanese investor, remains unconfirmed and is worth watching for a follow-up announcement given Scimplify’s stated plan to expand production into Japan as well as the US.
Predictions: What Comes Next for Scimplify and the Sector
- Expect Scimplify to name its first confirmed US manufacturing partner, likely tied to Teknor Apex’s existing plant network, within the next two to three quarters as technology-transfer work gets underway.
- The unnamed Japanese investor Santhosh referenced is likely to be confirmed alongside concrete details of Scimplify’s Japan production plans, given the company’s stated one-year timeline for both US and Japan expansion.
- Scinode’s $2 million development budget will likely be the first tranche of several, as AI-driven process design becomes a selling point Scimplify uses to win additional strategic investors beyond this round.
- Expect more specialty chemical and critical-materials startups to adopt Scimplify’s customer-as-investor funding structure over the next year, as large industrial buyers look for ways to lock in alternative supply outside concentrated markets.
- Scimplify’s still-undisclosed valuation is likely to surface in press coverage once the company raises again or discloses figures ahead of a future funding round, given how closely its peers’ valuations tend to get tracked once a company crosses $75 to $100 million in cumulative funding.
Open Questions and Risks
Several details around this round remain genuinely unresolved rather than simply unreported. Scimplify’s valuation has not been disclosed, and the company reportedly declined to share it, which makes it difficult to judge how much dilution the $25 million round represents relative to the $80 million raised previously. The identity of the Japanese investor Santhosh referenced has not been confirmed in any report reviewed for this story, and the conflicting $7.5 million versus $10 million figures for US investment mean the actual scale of the American buildout is not yet settled.
There is also execution risk inherent to any specialty chemicals qualification process. Technology transfer, pilot batches, and validation batches are standard industry checkpoints precisely because they are where most new suppliers fail to meet a customer’s specification on the first attempt. Scimplify’s AI platform may compress the design and prediction stage, but it cannot eliminate the physical testing and regulatory review that qualification ultimately requires.
Frequently Asked Questions
What is Scimplify and what does it make?
Scimplify is a Bengaluru-based specialty chemicals startup that makes critical materials used in semiconductors, defense, energy, batteries, and AI infrastructure, using an AI platform called Scinode to design production processes.
How much did Scimplify just raise, and who led the round?
Scimplify raised $25 million in an all-equity strategic funding round led by Hitachi Ventures, with Henkel and Teknor Apex joining as new investors alongside existing backers Accel India, Bertelsmann India Investments, Omnivore, and 3one4 Capital.
How much total funding has Scimplify raised to date?
The new $25 million round brings Scimplify’s total equity funding to $80 million since its founding, according to reports on the deal.
What will Scimplify do with the money?
Scimplify plans to expand research, processing, and manufacturing capabilities in the United States, qualify American manufacturing partners, and put $2 million into further development of its Scinode AI platform. Reports differ on the exact US-focused spend, citing figures of roughly $7.5 million and roughly $10 million over two years.
What is Scinode?
Scinode is Scimplify’s AI software platform, used to predict chemical synthesis routes, simulate factory production before a line is built, and coordinate R&D, quality, sourcing, and regulatory workflows.
Is Scimplify’s valuation known?
No. Scimplify has not disclosed its valuation following the round, and the company reportedly declined to share the figure.
When will Scimplify’s US and Japan expansion happen?
Scimplify has said it plans to expand its production network into the United States and Japan over the following year, though specific manufacturing partners and sites have not yet been confirmed publicly.
Why are Henkel and Teknor Apex investing in a chemicals supplier rather than just buying from it?
Both companies are existing or prospective customers of specialty chemical inputs, and taking equity stakes gives them closer influence over Scimplify’s production roadmap and priority access to supply, a structure increasingly common in critical-materials and deep-tech funding.
